ReCode Therapeutics retweeted
Congrats to @ReCodeTx on the successful closing of their $80 million Series B financing! Excited to support ReCode as they advance their novel LNP platform, which has the potential to reach a broad spectrum of diseases involving multiple organs and tissue. #biotech #vidaportfolio
At ReCode, we’re working to unleash the power #genetic medicines for underserved patients with life-limiting #respiratory diseases.
We're pleased to announce our raise of an $80 million #SeriesB financing to help execute this goal. Learn more here: bit.ly/rtxsrsb #RNA
ReCode Therapeutics retweeted
Congratulations to @ReCodeTx for closing $80M in Series B funding to expand its drug pipeline for respiratory diseases! Financing co-led by Pfizer Ventures and EcoR1 Capital, joined by MPM as well as other world class syndicate partners. #Biotechnology
ReCode's CF program uses nonviral lipid nanoparticles to deliver mRNA that aim to restore function of the cystic fibrosis transmembrane conductance regulator fiercebiotech.com/biotech/an…
ReCode Therapeutics retweeted
The Series B follows an oversubscribed $80 million Series A ReCode raised last March. At the time, it was the largest funding round to come out of Dallas-Fort Worth. buff.ly/3C9Fp3a
ReCode Therapeutics retweeted
ReCode Therapeutics reels in $80 million in funding from leading Big Pharma investors buff.ly/3B3ikOl
ReCode Therapeutics retweeted
Venture arms of @Pfizer & @Sanofi joined an $80M Series B round for @ReCodeTx, which is developing tech to target delivery of genetic medicines to specific tissues/organs in the body. @frankvinluan spoke w/ ReCode’s CEO about the #startup’s plans medcitynews.com/2021/10/reco… #biotech








